The Lancet · 2010 · 820 citations · 34 references
MedicineHematologyPharmacotherapyHematologic OncologyImmunotherapyStem Cell TransplantationAutologous Stem Cell TransplantationHematologic Malignancy PharmacotherapyHematologic Malignancy TherapyHematopoietic Stem Cell Transplant PharmacotherapyHematopoietic Stem Cell TransplantationMultiple MyelomaAutologous Stem Cell InfusionAutologous Stem Cell TherapyBortezomib TherapyLenalidomide TherapyMultiple Myeloma TherapyMultiple Myeloma TreatmentRemission Induction TherapyTransplantation For Hematologic Malignancies
34
International Staging System for Multiple Myeloma
Philip R. Greipp, Jesús F. San Miguel, Brian G.M. Durie et al. · Journal of Clinical Oncology · 2005 · 2.9K citations
Medicine, Hematology, Oncology +14
A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
Paul G. Richardson, Bart Barlogie, James R. Berenson et al. · New England Journal of Medicine · 2003 · 2.6K citations · Full text
International uniform response criteria for multiple myeloma
Brian G.M. Durie, J-L Harousseau, Jesús F. San Miguel et al. · Leukemia · 2006 · 2.6K citations
Medicine, Hematology, Oncology +12
M Ichel A Ttal, J Ean, A.A. D uuml nne et al. · 2013 · 2.2K citations
Medicine, Hematology, Oncology +14